Submit Your Opportunity
Information on how to submit a partnering opportunity direct to Boehringer Ingelheim’s Business Development & Licensing team
Szukaj
Research Beyond Borders Partnering
Our Research Beyond Borders team is looking for emerging science and technology opportunities. Learn more about partnering with us.
Behind the Lab
Delve behind the lab to see how our Retinal Health scientists are spearheading research into novel therapeutics to treat retinopathies.
Bigger role in ensuring food security
As the world population is projected to reach 9.8 billion in 2050, animal health becomes fundamental to ensure both animal well-being and global protein supply.
Guardians for health
sA global initiative to reduce mortality, cardiovascular and kidney complications in type 2 diabetes through adherence to clinical guideline.
We’re All In
Watch our video to learn about our approach to innovation and partnerships
Nota metodologiczna do Raportu Przejrzystości - Boehringer Ingelheim Sp. z o.o.
Światowy Dzień Chorób Rzadkich 2021
Rzadkie, ale nie zapomniane: dlaczego wsparcie medyczne dla około 30 milionów osób w UE cierpiących na choroby rzadkie1 jest nie do przecenienia
Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives.
Our Contribution
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come.
Boehringer Ingelheim Academy
Find out more about our networking and educational initiative
2023 06 BI PL Nota metodologiczna
Methodological Note to the Transparency Report of Boehringer Ingelheim Sp. z o.o.
Infarma (raport przejrzystości 2022) PL
Infarma (raport przejrzystości 2022) ENG
Spiolto Respimat_ChPL
Spiolto Respimat_Ulotka_15.12.2022
2024_01_31_BI_PL_Nota metodologiczna_PAGs.2023
Informacja o ochronie danych na stronie internetowej
2023_06_16_BI_PL_Nota metodologiczna_PAGs.2022
Informacja o ochronie danych w przypadku monitoringu wizyjnego
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Labor & Human Rights
Suppliers shall support and respect the protection of internationally proclaimed human rights.
Our Innovation Strategy
Our discovery research strategy is designed to sustain our track record of innovation and look for new and breakthrough medicines.
Europe needs a vibrant research eco-system
At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.